Reduced levels of Nrg4 are linked to obesity, insulin resistance, diabetes, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease, inflammation, oxidative stress, and macrovascular diseases such as coronary artery disease and myocardial infarction. Here, NRG4 is linked to metabolic dysfunction-associated steatotic liver disease.